AINTZANE
ASUMENDI MALLEA
![Foto de AINTZANE](/img/nophoto.png)
![Foto de Instituto de Investigación Sanitaria Biocruces Bizkaia](/img/noimage_org.png)
Instituto de Investigación Sanitaria Biocruces Bizkaia
Barakaldo, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Investigación Sanitaria Biocruces Bizkaia (19)
2024
-
Lipid fingerprint-based histology accurately classifies nevus, primary melanoma, and metastatic melanoma samples
International Journal of Cancer, Vol. 154, Núm. 4, pp. 712-722
-
PLGA-PEI nanoparticle covered with poly(I:C) for personalised cancer immunotherapy
Drug Delivery and Translational Research
2023
-
A Universal Antigen-Ranking Method to Design Personalized Vaccines Targeting Neoantigens against Melanoma
Life, Vol. 13, Núm. 1
-
Computational and Experimental Evaluation of the Immune Response of Neoantigens for Personalized Vaccine Design
International Journal of Molecular Sciences, Vol. 24, Núm. 10
-
Melanoma Clinical Decision Support System: An Artificial Intelligence-Based Tool to Diagnose and Predict Disease Outcome in Early-Stage Melanoma Patients
Cancers, Vol. 15, Núm. 7
-
Melanoma and Nevi Subtype Histopathological Characterization with Optical Coherence Tomography
Life, Vol. 13, Núm. 3
-
Pirin is a prognostic marker of human melanoma that dampens the proliferation of malignant cells by downregulating JARID1B/KDM5B expression
Scientific Reports, Vol. 13, Núm. 1
-
Small extracellular vesicle-based human melanocyte and melanoma signature
Pigment Cell and Melanoma Research
2022
-
Association of TYR SNP rs1042602 with Melanoma Risk and Prognosis
Life, Vol. 12, Núm. 12
-
Upregulated phospholipase D2 expression and activity is related to the metastatic properties of melanoma
Oncology Letters, Vol. 23, Núm. 5
2021
-
A uhplc-mass spectrometry view of human melanocytic cells uncovers potential lipid biomarkers of melanoma
International Journal of Molecular Sciences, Vol. 22, Núm. 21
-
Soluble pd-l1 is an independent prognostic factor in clear cell renal cell carcinoma
Cancers, Vol. 13, Núm. 4, pp. 1-17
-
The multifunctional role of SPANX-A/D protein subfamily in the promotion of pro-tumoural processes in human melanoma
Scientific Reports, Vol. 11, Núm. 1
2020
-
BRAF V600E mutational load as a prognosis biomarker in malignant melanoma
PLoS ONE, Vol. 15, Núm. 3
-
RKIP regulates differentiation-related features in melanocytic cells
Cancers, Vol. 12, Núm. 6, pp. 1-22
-
Serum markers improve current prediction of metastasis development in early-stage melanoma patients: a machine learning-based study
Molecular Oncology, Vol. 14, Núm. 8, pp. 1705-1718
2019
-
Altered expression of renin-angiotensin system receptors throughout colorectal adenoma-adenocarcinoma sequence
International Journal of Medical Sciences, Vol. 16, Núm. 6, pp. 813-821
-
Imaging Mass Spectrometry–Based Lipidomic Approach to Classification of Architectural Features in Nevi
Journal of Investigative Dermatology, Vol. 139, Núm. 9, pp. 2055-2058.e7
2016
-
Vitronectin and dermcidin serum levels predict the metastatic progression of AJCC I–II early-stage melanoma
International Journal of Cancer, Vol. 139, Núm. 7, pp. 1598-1607